376 related articles for article (PubMed ID: 31596097)
1. Bioconjugation of Cyclometalated Gold(III) Lipoic Acid Fragments to Linear and Cyclic Breast Cancer Targeting Peptides.
Śmiłowicz D; Slootweg JC; Metzler-Nolte N
Mol Pharm; 2019 Nov; 16(11):4572-4581. PubMed ID: 31596097
[TBL] [Abstract][Full Text] [Related]
2. Bioconjugates of Co(III) complexes with Schiff base ligands and cell penetrating peptides: Solid phase synthesis, characterization and antiproliferative activity.
Śmiłowicz D; Metzler-Nolte N
J Inorg Biochem; 2020 May; 206():111041. PubMed ID: 32120161
[TBL] [Abstract][Full Text] [Related]
3. Luminescent Bimetallic Ir
Luengo A; Marzo I; Reback M; Daubit IM; Fernández-Moreira V; Metzler-Nolte N; Gimeno MC
Chemistry; 2020 Sep; 26(53):12158-12167. PubMed ID: 32542887
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of monofunctional platinum(iv) carboxylate precursors for use in Pt(iv)-peptide bioconjugates.
Smiłowicz D; Metzler-Nolte N
Dalton Trans; 2018 Nov; 47(43):15465-15476. PubMed ID: 30334055
[TBL] [Abstract][Full Text] [Related]
5. Gold(III) complexes as potential antitumor agents: solution chemistry and cytotoxic properties of some selected gold(III) compounds.
Messori L; Abbate F; Marcon G; Orioli P; Fontani M; Mini E; Mazzei T; Carotti S; O'Connell T; Zanello P
J Med Chem; 2000 Sep; 43(19):3541-8. PubMed ID: 11000008
[TBL] [Abstract][Full Text] [Related]
6. New Variations on the Theme of Gold(III) C
Carboni S; Zucca A; Stoccoro S; Maiore L; Arca M; Ortu F; Artner C; Keppler BK; Meier-Menches SM; Casini A; Cinellu MA
Inorg Chem; 2018 Dec; 57(23):14852-14865. PubMed ID: 30457328
[TBL] [Abstract][Full Text] [Related]
7. Overcoming cisplatin resistance using gold(III) mimics: anticancer activity of novel gold(III) polypyridyl complexes.
Palanichamy K; Sreejayan N; Ontko AC
J Inorg Biochem; 2012 Jan; 106(1):32-42. PubMed ID: 22112837
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, structural characterization, docking simulation and in vitro antiproliferative activity of the new gold(III) complex with 2-pyridineethanol.
Malik M; Bieńko DC; Komarnicka UK; Kyzioł A; Dryś M; Świtlicka A; Dyguda-Kazimierowicz E; Jedwabny W
J Inorg Biochem; 2021 Feb; 215():111311. PubMed ID: 33246642
[TBL] [Abstract][Full Text] [Related]
9. Selective cytotoxicity of cyclometalated gold(III) complexes on Caco-2 cells is mediated by G2/M cell cycle arrest.
Abás E; Bellés A; Rodríguez-Diéguez A; Laguna M; Grasa L
Metallomics; 2021 Jul; 13(7):. PubMed ID: 34114030
[TBL] [Abstract][Full Text] [Related]
10. Stabilization of gold(I) and gold(III) complexes by pyridil bis{3-hexamethylene-iminylthiosemicarbazone}: spectroscopic, structural and computational study.
Castiñeiras A; Dehnen S; Fuchs A; García-Santos I; Sevillano P
Dalton Trans; 2009 Apr; (15):2731-9. PubMed ID: 19333496
[TBL] [Abstract][Full Text] [Related]
11. Gold(III) bis(thiosemicarbazonate) compounds in breast cancer cells: Cytotoxicity and thioredoxin reductase targeting.
Rodríguez-Fanjul V; López-Torres E; Mendiola MA; Pizarro AM
Eur J Med Chem; 2018 Mar; 148():372-383. PubMed ID: 29471123
[TBL] [Abstract][Full Text] [Related]
12. Influence of the Linker Length on the Cytotoxicity of Homobinuclear Ruthenium(II) and Gold(I) Complexes.
Batchelor LK; Păunescu E; Soudani M; Scopelliti R; Dyson PJ
Inorg Chem; 2017 Aug; 56(16):9617-9633. PubMed ID: 28758743
[TBL] [Abstract][Full Text] [Related]
13. (C^N
Williams M; Green AI; Fernandez-Cestau J; Hughes DL; O'Connell MA; Searcey M; Bertrand B; Bochmann M
Dalton Trans; 2017 Oct; 46(39):13397-13408. PubMed ID: 28945262
[TBL] [Abstract][Full Text] [Related]
14. Mononuclear gold(iii) complexes with l-histidine-containing dipeptides: tuning the structural and biological properties by variation of the N-terminal amino acid and counter anion.
Warżajtis B; Glišić BĐ; Savić ND; Pavic A; Vojnovic S; Veselinović A; Nikodinovic-Runic J; Rychlewska U; Djuran MI
Dalton Trans; 2017 Feb; 46(8):2594-2608. PubMed ID: 28155927
[TBL] [Abstract][Full Text] [Related]
15. Conjugation of a gold(iii) complex with vitamin B1 and chlorambucil derivatives: anticancer evaluation and mechanistic insights.
Tabrizi L; Abyar F
Metallomics; 2020 May; 12(5):721-731. PubMed ID: 32196031
[TBL] [Abstract][Full Text] [Related]
16. Histidine-iridium(III) coordination-based peptide luminogenic cyclization and cyclo-RGD peptides for cancer-cell targeting.
Ma X; Jia J; Cao R; Wang X; Fei H
J Am Chem Soc; 2014 Dec; 136(51):17734-7. PubMed ID: 25486120
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and structure-activity relationship study of organometallic bioconjugates of the cyclic octapeptide octreotate.
Gross A; Habig D; Metzler-Nolte N
Chembiochem; 2013 Dec; 14(18):2472-9. PubMed ID: 24218362
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, characterization, cytotoxic and antitubercular activities of new gold(I) and gold(III) complexes containing ligands derived from carbohydrates.
Chaves JD; Damasceno JL; Paula MC; de Oliveira PF; Azevedo GC; Matos RC; Lourenço MC; Tavares DC; Silva H; Fontes AP; de Almeida MV
Biometals; 2015 Oct; 28(5):845-60. PubMed ID: 26091950
[TBL] [Abstract][Full Text] [Related]
19. The synthesis, chemical and biological properties of dichlorido(azpy)gold(III) chloride (azpy=2-(phenylazo)pyridine) and the gold-induced conversion of the azpy ligand to the chloride of the novel tricyclic pyrido[2,1-c][1,2,4]benzotriazin-11-ium cation.
Garza-Ortiz A; den Dulk H; Brouwer J; Kooijman H; Spek AL; Reedijk J
J Inorg Biochem; 2007 Nov; 101(11-12):1922-30. PubMed ID: 17637477
[TBL] [Abstract][Full Text] [Related]
20. Novel Papaverine Metal Complexes with Potential Anticancer Activities.
Gaber A; Alsanie WF; Kumar DN; Refat MS; Saied EM
Molecules; 2020 Nov; 25(22):. PubMed ID: 33233775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
